Gene: CCSER2
Official Full Name: coiled-coil serine rich protein 2provided by HGNC
Gene Summary: Predicted to enable microtubule binding activity. Predicted to be involved in microtubule bundle formation. Predicted to be located in cytoplasm and cytoskeleton. Predicted to be active in microtubule cytoskeleton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21738 | CCSER2 Knockout cell line (HeLa) | Human | CCSER2 | 1:3~1:6 | Negative | Online Inquiry |
KO21739 | CCSER2 Knockout cell line (HCT 116) | Human | CCSER2 | 1:2~1:4 | Negative | Online Inquiry |
KO21740 | CCSER2 Knockout cell line (HEK293) | Human | CCSER2 | 1:3~1:6 | Negative | Online Inquiry |
KO21741 | CCSER2 Knockout cell line (A549) | Human | CCSER2 | 1:3~1:4 | Negative | Online Inquiry |
CCSER2 Gene Knockout Cell Lines are specially engineered cell lines in which the CCSER2 gene has been targeted and disrupted through advanced CRISPR-Cas9 technology. This specific genetic manipulation creates a valuable tool for researchers, allowing them to investigate the functional role of the CCSER2 gene in various biological processes. By creating a model that lacks this gene, scientists can study the downstream effects on cellular behavior, signaling pathways, and overall physiology, thereby elucidating the gene's contributions to health and disease.
The primary mechanism by which CCSER2 knockout cell lines operate lies in the absence of the CCSER2 protein, which has been implicated in critical cellular functions including DNA repair, cellular proliferation, and apoptosis. These knockout lines facilitate research into the gene's role in cancer biology, stem cell research, and therapeutic responses, laying the groundwork for potential novel treatment strategies and biomarker identification.
In terms of scientific significance, CCSER2 Gene Knockout Cell Lines are essential for high-throughput screening and functional assays in both academic and clinical settings. They provide a consistent and reproducible model that can be used for drug discovery, genetic research, and the development of targeted therapies. Compared to alternative models, such as wild-type cell lines or cells with incomplete knockdowns, these fully validated knockout lines offer a clear advantage in specificity and reliability, reducing background noise in experiments and enhancing the clarity of results.
Researchers, clinicians, and pharmaceutical companies alike will find these cell lines invaluable for their potential to uncover new insights into genetic mechanisms and disease pathogenesis. By facilitating a deeper understanding of CCSER2-related functions, these knockout lines can lead to breakthrough findings that inform therapeutic approaches.
Our company specializes in the development and production of advanced genetic models, leveraging cutting-edge techniques and an extensive understanding of molecular biology. With a commitment to quality and innovation, we empower researchers to push the boundaries of scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.